Please wait...
GulfBase Live Support
Leave a message and our representative will contact you soon
- ADX names Mena start-up Thndr as remote retail trading member
- Mered expands UAE operations with new Abu Dhabi office
- Bahrain All Share Index closes lower, Islamic Index closes higher
- Burjeel reports 129% increase in Q2 net profit, revenue grows 18.7%
- Saudi Maaden H1 profit up 73% on higher sales; revenue hits $4.8bn
- IQ reports QR2bn net profit in H1, approves 26% interim dividend
- 65% Omanis in private sector earn less than RO600
- Local banks record higher credit issuance in June; reflects positive outlook on Qatar economy
- S&P Affirms China's Sovereign Credit Rating at A+ with Stable Outlook
- Saudi stock market may open to global investors, regulator says
20/05/2025 05:00 AST
Gulf Pharmaceutical Industries (Julphar) plans to invest Dh300 million over the next five years to expand its manufacturing base and localise advanced pharmaceutical technologies, CEO Basel Ziyadeh confirmed on Monday.
In statements made to the Emirates News Agency (WAM) on the sidelines of the first day of the "Make it in the Emirates 2025", Ziyadeh said the investment will be made in collaboration with global partners and aims to support the UAE's non-oil economy by increasing pharmaceutical exports.
He added that Julphar currently exports over 80% of its production to around 40 markets worldwide, underscoring the strength of its manufacturing infrastructure and local talent. Over the past three years, the company has already invested Dh100 million in upgrades and introduced more than 35 new products for both local and international markets.
Established over 45 years ago, Julphar is now one of the largest pharmaceutical manufacturers in the Arab region.
Gulfnews
04/04/2018
Julphar, a leading pharmaceutical manufacturer in the region, has been ranked as the number one pharmaceutical company in the UAE by IMS Health February 2018 panel, reflecting a strong double digit s
Trade Arabia
07/03/2018
Julphar, one of the largest pharmaceutical manufacturers in the Middle East and Africa, recorded sales of Dh1.3 billion for the year ending December 31, 2017, despite a challenging and rapidly changi
Gulf News
20/11/2017
Julphar Gulf Pharmaceutical Industries on Sunday said its net profit for the third quarter of this year reached Dh86 million, and that revenues for the first three quarters of this year amounted to D
Gulfnews
| Ticker | Price | Volume |
|---|
| Ticker | Price | Change |
|---|---|---|
| PUREHEALTH | 2.94 | 0.00 (0.00 |
| MIDAN | 750.00 | 1.00 (0.13 |
| GMPC | 2.16 | 0.00 (0.00 |
| ATC.KW | 519.00 | -17.00 (-3.18 |
| BURJEEL | 1.51 | -0.03 (-1.95 |
08/08/2025
Burjeel Holdings, a leading super-specialty healthcare services provider in MENA, has delivered a strong top-line growth of 18.7% to AED1,403 million ($381.98 million) in Q2 2025, driven by a 12.1% i
Trade Arabia
08/08/2025
Saudi Arabian Mining Company (Maaden) has reported a 73% jump in its net profit for the first half, which soared to SAR3.47billion ($924 million) from SAR2.01 billion ($535 million) last year, mainly
Trade Arabia
08/08/2025
Market heavyweight Industries Qatar (IQ) - the holding entity of Qatar Petrochemicals, Qatar Fertiliser and Qatar Steel - has reported net profit of QR2bn in the first half (H1) of 2025.
The
Gulf Times
08/08/2025
Aramex reported group revenues of Dh3.06 billion for the first half of 2025, marking a 1% year-on-year increase, as growth in domestic and regional logistics offset weakness in international express
Gulfnews
08/08/2025
Parkin Company PJSC, the city's largest paid public parking provider, reported a record 56% year-on-year rise in Q2 2025 revenue to Dh320 million, driven by higher public parking tariffs, strong enfo
Gulfnews
Financial Information Co.
P.O. Box 69410, Jeddah 11547, Saudi Arabia